ACC.26 - In this expert interview filmed at ACC.26 in New Orleans, Prof. Felipe Martínez discusses how late-breaking heart failure data are reshaping contemporary pharmacological management. The conversation focuses on new spironolactone results, advanced hemodynamic strategies in HFpEF, and the expanding role of cardiometabolic therapies, including GLP‑1 receptor agonists, in optimising outcomes for complex heart failure patients.

Drawing on his experience as a leading heart failure pharmacologist and past President of the International Society of Cardiovascular Pharmacotherapy (ISCP), Prof. Martínez offers practical guidance on how cardiology teams can integrate ACC.26 evidence into day‑to‑day prescribing and team‑based care.

This interview is produced in collaboration with the International Society of Cardiovascular Pharmacotherapy (ISCP) and European Cardiology Review (ECR).

Editor: Mirjam Boros

Videographer: David Ben-Harosh